Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

COMMENT

LETTER

Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?

Maurizio Guastalegname, Alfredo Vallone

Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2020 July 28, 71 (15): 888-889

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Christian A Devaux, Jean-Marc Rolain, Philippe Colson, Didier Raoult International Journal of Antimicrobial Agents 2020, 55 (5): 105938

Aminoquinolines Against Coronavirus Disease 2019 (COVID-19): Chloroquine or Hydroxychloroquine. Zahra Sahraei, Minoosh Shabani, Shervin Shokouhi, Ali Saffaei International Journal of Antimicrobial Agents 2020 March 16, : 105945

A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. Andrea Cortegiani, Giulia Ingoglia, Mariachiara Ippolito, Antonino Giarratano, Sharon Einav Journal of Critical Care 2020 March 10

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Jianjun Gao, Zhenxue Tian, Xu Yang Bioscience Trends 2020 March 16, 14 (1): 72-73

COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. Dan Zhou, Sheng-Ming Dai, Qiang Tong Journal of Antimicrobial Chemotherapy 2020 March 20

[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]. (no author information available yet) Chinese Journal of Tuberculosis and Respiratory Diseases 2020 February 20, 43: E019

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Philippe Gautret, Jean-Christophe Lagier, Philippe Parola, Van Thuan Hoang, Line Meddeb, Morgane Mailhe, Barbara Doudier, Johan Courjon, Valérie Giordanengo, Vera Esteves Vieira, Hervé Tissot Dupont, Stéphane Honoré, Philippe Colson, Eric Chabrière, Bernard La Scola, Jean-Marc Rolain, Philippe Brouqui, Didier Raoult International Journal of Antimicrobial Agents 2020 March 20, : 105949

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Xueting Yao, Fei Ye, Miao Zhang, Cheng Cui, Baoying Huang, Peihua Niu, Xu Liu, Li Zhao, Erdan Dong, Chunli Song, Siyan Zhan, Roujian Lu, Haiyan Li, Wenjie Tan, Dongyang Liu Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2020 March 9

Discovering drugs to treat coronavirus disease 2019 (COVID-19). Liying Dong, Shasha Hu, Jianjun Gao Drug Discoveries & Therapeutics 2020, 14 (1): 58-60

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips